Ashley Utz

Oct 17, 2023 | biorxiv.org | Duo Xu |Abigail Powell |Mrinmoy Sanyal |Ashley Utz

AbstractEbola virus causes hemorrhagic fever in humans and poses a significant threat to global public health. Although two viral vector vaccines have been approved to prevent Ebola virus disease, they are distributed in the limited ring vaccination setting and only indicated for prevention of infection from orthoebolavirus zairense (EBOV) - one of three orthoebolavirus species that have caused previous outbreaks.